Query
Find articles
Pick a keyword, optionally a second one to combine it with (and, or, either but not both, or but not), then narrow the articles down by text, source and time range. Keywords update the results right away; filters apply with their button.
Query
Who picked it up when
CBS News mentioned it first (Oct 22, 2026, 7:40 PM EDT). Least biased outlets followed 4 days later. No left-leaning outlet mentioned it.
One row per source with a matching article, from the most left-leaning on top: a dot for each article, on a bar for each stretch of its coverage (a pause of more than 24 hours starts a new one). Hover or tap a dot for the headline, click it to read the article.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
Results
4 articles mention GLP-1 drug in the last 7 days (Oct 20 to Oct 26).
| Article | |||
|---|---|---|---|
| The Hill | Open enrollment begins: What Medicare beneficiaries need to know for 2027The Hill From GLP-1 drug prices to higher deductibles, several Medicare changes could affect seniors' wallets in 2027. | 0.50 | |
| The Hill | Ozempic users may face protein, vitamin D deficiencies, experts warnThe Hill As GLP-1 drugs help people eat less, doctors are increasingly concerned about what patients may be missing nutritionally. | 0.60 | |
| CBS News | More people now use GLP-1s to lose weight than for other health issuesCBS News Growing usage of GLP-1 drugs for weight loss is reshaping how consumers shop for food and clothes, according to consulting firm EY-Parthenon. | 0.80● | |
| CBS News | Here's how GLP-1 drugs are changing how people shopCBS News New research on GLP-1 drug usage from EY-Parthenon shows that weight loss is now the most popular use of the drug once dedicated to diabetes patients. CBS News' Megan Cerullo reports on how the drugs are changing spending habits for users. | 0.90● |
Source leans by Media Bias/Fact Check.
Narrow further
Other keywords in the matching articles: the share of them that mention each, with the number of articles. The search icon searches for GLP-1 drug and that keyword, keeping the text, sources, source type and time range.
Coverage by source
The share of each source's stories in the last 7 days that match the query, from left to right. Sort the table to reorder the bars.
Source lean:leftcenterright
Source leans by Media Bias/Fact Check.
| The Hill | 0.5% | 2 | 418 |
| CBS News | 0.4% | 2 | 486 |
Coverage by lean
The share of stories that match the query, in the last 7 days, averaged over the outlets of each political lean with at least 3 stories. The groups differ in size, so a single outlet weighs more in the smaller ones.
- Left-leaning0 of 15 sources
- 0.0%
- Least biased1 of 8 sources
- 0.1%
- Right-leaning1 of 15 sources
- <0.1%
Lean index +0.4: covered about evenly across the spectrum
Each outlet at its MBFC bias score, from −10 (far left) to +10 (far right), as high as the share of its stories that match the query. The lean index is the average score of the outlets covering it, weighted by that share.
lean indexour sources' average (+0.4)leftcenterright
Bias scores by Media Bias/Fact Check.
1 source has no MBFC bias score and is not shown.
Source leans based on ratings by Media Bias/Fact Check.